Last 12 months
Inside the activity.
1 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 30, 2021 Filed May 3, 2021 20:00 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Shares, No Par Value | 7,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014906 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,937 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:20 UTC |
WECHSLER AMY BDirector
|
GrantCommon Shares, No Par Value | 216 | $31.74 | $6,855.84 |
DisclosureSEC source: 0001127602-21-012770 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,717 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:18 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 1,188 | $31.74 | $37,707.12 |
DisclosureSEC source: 0001127602-21-012766 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,892 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:14 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 952 | $31.74 | $30,216.48 |
DisclosureSEC source: 0001127602-21-012752 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,392 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:11 UTC |
Miller Steven DDirector
|
GrantCommon Shares, No Par Value | 148 | $31.74 | $4,697.52 |
DisclosureSEC source: 0001127602-21-012735 · form4.xml · nonDerivative · entry 1 Miller Steven D · CIK 0001844277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 992 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:09 UTC |
ICAHN BRETTDirector
|
GrantCommon Shares, No Par Value | 126 | $31.74 | $3,999.24 |
DisclosureSEC source: 0001127602-21-012726 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 870 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:06 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Shares, No Par Value | 1,070 | $31.74 | $33,961.80 |
DisclosureSEC source: 0001127602-21-012714 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,292 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:38 UTC |
Miller Steven DDirector
|
GrantCommon Shares, No Par Value | 744 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-011920 · form4.xml · nonDerivative · entry 1 Miller Steven D · CIK 0001844277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 844 F1 · shares: Represents Restricted Share Units ("RSUs"), each representing a contingent right to receive one Common Share, no par value, of Bausch Health Companies Inc., which will vest immediately before the 2021 Annual Meeting of Shareholders. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:34 UTC |
ICAHN BRETTDirector
|
GrantCommon Shares, No Par Value | 744 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-011915 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 744 F1 · shares: Represents Restricted Share Units ("RSUs"), each representing a contingent right to receive one Common Share, no par value, of Bausch Health Companies Inc., which will vest immediately before the 2021 Annual Meeting of Shareholders. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 20:08 UTC |
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL
|
Tax withholdingCommon Shares, No Par Value | 796 | $32.82 | $26,124.72 |
DisclosureSEC source: 0001127602-21-010592 · form4.xml · nonDerivative · entry 1 ACKERMANN CHRISTINA · CIK 0001681871 · EVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,758 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 01:59 UTC |
Herendeen PaulEVP and CFO
|
Tax withholdingCommon Shares, No Par Value | 59,519 | $32.97 | $1,962,341.43 |
DisclosureSEC source: 0001127602-21-010166 · form4.xml · nonDerivative · entry 3 Herendeen Paul · CIK 0001374175 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,618 F3 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs and RSUs. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 02:01 UTC |
PAPA JOSEPH CDirector · CHAIRMAN & CEO
|
Tax withholdingCommon Shares, No Par Value | 231,188 | $32.97 | $7,622,268.36 |
DisclosureSEC source: 0001127602-21-010168 · form4.xml · nonDerivative · entry 3 PAPA JOSEPH C · CIK 0001242215 · Director · CHAIRMAN & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,039,978 F3 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs and RSUs. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 01:55 UTC |
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l
|
Tax withholdingCommon Shares, No Par Value | 12,461 | $32.97 | $410,839.17 |
DisclosureSEC source: 0001127602-21-010164 · form4.xml · nonDerivative · entry 3 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,638 F3 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs and RSUs. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 01:51 UTC |
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER
|
Tax withholdingCommon Shares, No Par Value | 7,361 | $32.97 | $242,692.17 |
DisclosureSEC source: 0001127602-21-010162 · form4.xml · nonDerivative · entry 3 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,184 F3 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs and RSUs. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 01:49 UTC |
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l
|
Tax withholdingCommon Shares, No Par Value | 17,480 | $32.97 | $576,315.60 |
DisclosureSEC source: 0001127602-21-010160 · form4.xml · nonDerivative · entry 3 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,426 F3 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs and RSUs. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 01:46 UTC |
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL
|
Tax withholdingCommon Shares, No Par Value | 21,960 | $32.97 | $724,021.20 |
DisclosureSEC source: 0001127602-21-010158 · form4.xml · nonDerivative · entry 3 ACKERMANN CHRISTINA · CIK 0001681871 · EVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,554 F3 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs and RSUs. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:59 UTC |
Herendeen PaulEVP and CFO
|
Exercise / conversionRestricted Share Units · Derivative | 49,324 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010166 · form4.xml · derivative · entry 4 Herendeen Paul · CIK 0001374175 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 49,324 shares Expires 2021-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each PSU converts into Common Shares on a one-for-one basis F2 · price: Each PSU converts into Common Shares on a one-for-one basis F4 · derivative.exercise_date: The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. F4 · derivative.expiration_date: The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. F5 · balance_after: This PSU award was previously reported on a Form 4 filed on March 9, 2018 with the maximum potential award amount of 79,556 shares. Any portion of the award not vested as of the transaction date was cancelled as of that date. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:59 UTC |
Herendeen PaulEVP and CFO
|
GrantCommon Shares, No Par Value | 50,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-010166 · form4.xml · nonDerivative · entry 2 Herendeen Paul · CIK 0001374175 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 446,137 F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:59 UTC |
Herendeen PaulEVP and CFO
|
Exercise / conversionCommon Shares, No Par Value | 49,324 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010166 · form4.xml · nonDerivative · entry 1 Herendeen Paul · CIK 0001374175 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. F2 · price: Each PSU converts into Common Shares on a one-for-one basis Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 02:01 UTC |
PAPA JOSEPH CDirector · CHAIRMAN & CEO
|
Exercise / conversionRestricted Share Units · Derivative | 317,089 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010168 · form4.xml · derivative · entry 4 PAPA JOSEPH C · CIK 0001242215 · Director · CHAIRMAN & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 317,089 shares Expires 2021-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each PSU converts into Common Shares on a one-for-one basis. F2 · price: Each PSU converts into Common Shares on a one-for-one basis. F4 · derivative.exercise_date: The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. F4 · derivative.expiration_date: The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. F5 · balance_after: This PSU award was previously reported on a Form 4 filed on March 9, 2018 with the maximum potential award amount of 511,434 shares. Any portion of the award not vested as of the transaction date was cancelled as of that date. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 02:01 UTC |
PAPA JOSEPH CDirector · CHAIRMAN & CEO
|
GrantCommon Shares, No Par Value | 108,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-010168 · form4.xml · nonDerivative · entry 2 PAPA JOSEPH C · CIK 0001242215 · Director · CHAIRMAN & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,271,166 F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 02:01 UTC |
PAPA JOSEPH CDirector · CHAIRMAN & CEO
|
Exercise / conversionCommon Shares, No Par Value | 317,089 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010168 · form4.xml · nonDerivative · entry 1 PAPA JOSEPH C · CIK 0001242215 · Director · CHAIRMAN & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,162,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. F2 · price: Each PSU converts into Common Shares on a one-for-one basis. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:55 UTC |
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l
|
Exercise / conversionRestricted Share Units · Derivative | 5,637 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010164 · form4.xml · derivative · entry 4 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 5,637 shares Expires 2021-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each PSU converts into Common Shares on a one-for-one basis. F2 · price: Each PSU converts into Common Shares on a one-for-one basis. F4 · derivative.exercise_date: The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. F4 · derivative.expiration_date: The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. F5 · balance_after: This PSU award was previously reported on a Form 3 filed on August 10, 2018 with the target potential award amount of 4,546 shares. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:55 UTC |
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l
|
GrantCommon Shares, No Par Value | 17,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-010164 · form4.xml · nonDerivative · entry 2 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,099 F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:55 UTC |
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l
|
Exercise / conversionCommon Shares, No Par Value | 5,637 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010164 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. F2 · price: Each PSU converts into Common Shares on a one-for-one basis. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:51 UTC |
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER
|
Exercise / conversionRestricted Share Units · Derivative | 4,404 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010162 · form4.xml · derivative · entry 4 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,404 shares Expires 2021-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each PSU converts into Common Shares on a one-for-one basis. F2 · price: Each PSU converts into Common Shares on a one-for-one basis. F4 · derivative.exercise_date: The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. F4 · derivative.expiration_date: The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. F5 · balance_after: This PSU award was previously reported on a Form 4 filed on March 9, 2018 with the maximum potential award amount of 7,104 shares. Any portion of the award not vested as of the transaction date was cancelled as of that date. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:51 UTC |
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER
|
GrantCommon Shares, No Par Value | 13,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-010162 · form4.xml · nonDerivative · entry 2 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,545 F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:51 UTC |
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER
|
Exercise / conversionCommon Shares, No Par Value | 4,404 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010162 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. F2 · price: Each PSU converts into Common Shares on a one-for-one basis. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:49 UTC |
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l
|
Exercise / conversionRestricted Share Units · Derivative | 9,161 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010160 · form4.xml · derivative · entry 4 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,161 shares Expires 2021-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each PSU converts into Common Shares on a one-for-one basis. F2 · price: Each PSU converts into Common Shares on a one-for-one basis. F4 · derivative.exercise_date: The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. F4 · derivative.expiration_date: The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. F5 · balance_after: This PSU award was previously reported on a Form 4 filed on March 9, 2018 with the maximum potential award amount of 14,776 shares. Any portion of the award not vested as of the transaction date was cancelled as of that date. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:49 UTC |
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l
|
GrantCommon Shares, No Par Value | 28,144 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-010160 · form4.xml · nonDerivative · entry 2 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,906 F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:49 UTC |
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l
|
Exercise / conversionCommon Shares, No Par Value | 9,161 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010160 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. F2 · price: Each PSU converts into Common Shares on a one-for-one basis. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:46 UTC |
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL
|
Exercise / conversionRestricted Share Units · Derivative | 8,455 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010158 · form4.xml · derivative · entry 4 ACKERMANN CHRISTINA · CIK 0001681871 · EVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,455 shares Expires 2021-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each PSU converts into Common Shares on a one-for-one basis. F2 · price: Each PSU converts into Common Shares on a one-for-one basis. F4 · derivative.exercise_date: The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. F4 · derivative.expiration_date: The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. F5 · balance_after: This PSU award was previously reported on a Form 4 filed on March 9, 2018 with the maximum potential award amount of 13,638 shares. Any portion of the award not vested as of the transaction date was cancelled as of that date. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:46 UTC |
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL
|
GrantCommon Shares, No Par Value | 25,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-010158 · form4.xml · nonDerivative · entry 2 ACKERMANN CHRISTINA · CIK 0001681871 · EVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,514 F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:46 UTC |
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL
|
Exercise / conversionCommon Shares, No Par Value | 8,455 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010158 · form4.xml · nonDerivative · entry 1 ACKERMANN CHRISTINA · CIK 0001681871 · EVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. F2 · price: Each PSU converts into Common Shares on a one-for-one basis. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 23:03 UTC |
Spurr RobertPresident, Salix
|
GrantNon-qualified Stock Options (right To Purchase) · Derivative | 32,749 | $0.00 Strike: $32.56 | $0.00 |
DisclosureSEC source: 0001127602-21-009572 · form4.xml · derivative · entry 2 Spurr Robert · CIK 0001543795 · President, Salix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,749 Underlying: Common Shares, No Par Value · 32,749 shares Expires 2031-03-03 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 23:03 UTC |
Spurr RobertPresident, Salix
|
GrantCommon Shares, No Par Value | 23,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-009572 · form4.xml · nonDerivative · entry 1 Spurr Robert · CIK 0001543795 · President, Salix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,336 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 23:00 UTC |
PAPA JOSEPH CDirector · CHAIRMAN & CEO
|
GrantNon-qualified Stock Options (right To Purchase) · Derivative | 196,464 | $0.00 Strike: $32.56 | $0.00 |
DisclosureSEC source: 0001127602-21-009570 · form4.xml · derivative · entry 2 PAPA JOSEPH C · CIK 0001242215 · Director · CHAIRMAN & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,464 Underlying: Common Shares, No Par Value · 196,464 shares Expires 2031-03-03 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 23:00 UTC |
PAPA JOSEPH CDirector · CHAIRMAN & CEO
|
GrantCommon Shares, No Par Value | 74,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-009570 · form4.xml · nonDerivative · entry 1 PAPA JOSEPH C · CIK 0001242215 · Director · CHAIRMAN & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 845,823 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:58 UTC |
Herendeen PaulEVP and CFO
|
GrantNon-qualified Stock Options (right To Purchase) · Derivative | 91,684 | $0.00 Strike: $32.56 | $0.00 |
DisclosureSEC source: 0001127602-21-009566 · form4.xml · derivative · entry 2 Herendeen Paul · CIK 0001374175 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,684 Underlying: Common Shares, No Par Value · 91,684 shares Expires 2031-03-03 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:58 UTC |
Herendeen PaulEVP and CFO
|
GrantCommon Shares, No Par Value | 63,439 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-009566 · form4.xml · nonDerivative · entry 1 Herendeen Paul · CIK 0001374175 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,295 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:57 UTC |
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l
|
GrantNon-qualified Stock Options (right To Purchase) · Derivative | 32,749 | $0.00 Strike: $32.56 | $0.00 |
DisclosureSEC source: 0001127602-21-009564 · form4.xml · derivative · entry 2 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,749 Underlying: Common Shares, No Par Value · 32,749 shares Expires 2031-03-03 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:57 UTC |
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l
|
GrantCommon Shares, No Par Value | 23,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-009564 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,142 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:55 UTC |
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER
|
GrantNon-qualified Stock Options (right To Purchase) · Derivative | 16,374 | $0.00 Strike: $32.56 | $0.00 |
DisclosureSEC source: 0001127602-21-009562 · form4.xml · derivative · entry 2 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,374 Underlying: Common Shares, No Par Value · 16,374 shares Expires 2031-03-03 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:55 UTC |
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER
|
GrantCommon Shares, No Par Value | 10,298 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-009562 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,611 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:45 UTC |
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL
|
GrantNon-qualified Stock Options (right To Purchase) · Derivative | 52,392 | $0.00 Strike: $32.56 | $0.00 |
DisclosureSEC source: 0001127602-21-009554 · form4.xml · derivative · entry 2 ACKERMANN CHRISTINA · CIK 0001681871 · EVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,392 Underlying: Common Shares, No Par Value · 52,392 shares Expires 2031-03-03 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:45 UTC |
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL
|
GrantCommon Shares, No Par Value | 36,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-009554 · form4.xml · nonDerivative · entry 1 ACKERMANN CHRISTINA · CIK 0001681871 · EVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,079 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:52 UTC |
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l
|
GrantNon-qualified Stock Options (right To Purchase) · Derivative | 47,151 | $0.00 Strike: $32.56 | $0.00 |
DisclosureSEC source: 0001127602-21-009559 · form4.xml · derivative · entry 2 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,151 Underlying: Common Shares, No Par Value · 47,151 shares Expires 2031-03-03 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:52 UTC |
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l
|
GrantCommon Shares, No Par Value | 32,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-009559 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,601 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:50 UTC |
Spurr RobertPresident, Salix
|
Tax withholdingCommon Shares, No Par Value | 3,252 | $31.42 | $102,177.84 |
DisclosureSEC source: 0001127602-21-009220 · form4.xml · nonDerivative · entry 1 Spurr Robert · CIK 0001543795 · President, Salix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,444 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:47 UTC |
PAPA JOSEPH CDirector · CHAIRMAN & CEO
|
Tax withholdingCommon Shares, No Par Value | 28,192 | $31.42 | $885,792.64 |
DisclosureSEC source: 0001127602-21-009214 · form4.xml · nonDerivative · entry 1 PAPA JOSEPH C · CIK 0001242215 · Director · CHAIRMAN & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 771,673 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.